FDA Will Summarily Deny Petitions Submitted Solely To Block ANDA Approvals
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guidance in implementation of FDAAA provision outlines how FDA will weed out and deny petitions “with a primary purpose of delaying approval of an application.”.
You may also be interested in...
Citizen Petitions Seeking To Delay Product Approvals Continue To Swamp FDA
Agency's latest report to Congress highlights resource burden, implies legislative fix may better discourage frivolous petitions.
Citizen Petitions Face Strict Certification Requirements Under FDA Final Guidance
FDA will reject petitions that do not include exact language for certification and verification; hedge fund manager files citizen petition opposing approval of Neoprobe's Lymphoseek.
Citizen Petitions Face Strict Certification Requirements Under FDA Final Guidance
FDA will reject petitions that do not include exact language for certification and verification; hedge fund manager files citizen petition opposing approval of Neoprobe's Lymphoseek.